Where does GeneCraft, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GeneCraft, Inc. ranks #46,995 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GeneCraft, Inc. hold?

GeneCraft, Inc. holds 5 US utility patents granted between 2023 and 2025, spanning 5 technology areas.

What is GeneCraft, Inc.'s Innovation Score?

GeneCraft, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is GeneCraft, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for GeneCraft, Inc..

What does claim depth mean for GeneCraft, Inc.'s patents?

GeneCraft, Inc.'s patents average 10.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GeneCraft, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GeneCraft, Inc.

Q: What technology areas does GeneCraft, Inc. focus on?

GeneCraft, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genecraft ranks #46,995 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#46,995
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 10.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R46995 · Foreign Corporation #46,995 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,995/49,997
PHOTO-FINISH Gelmart Industries
CPC-NARROW C12N · 5 areas
INNOV-PAR 40.2/100
CLAIMS-PAR 10.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Gelmart Industries, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genecraft’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (15%) Velocity 20.0 pts (50%) Breadth 7.9 pts (20%) Claim depth 6.1 pts (15%)

Qualcomm Incorporated · highest

85
GeneCraft · this assignee

40
3D Lighting… · lowest

7

What this shows Genecraft's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genecraft?

Each dot is one of Genecraft’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genecraft’s own 10.2 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Genecraft vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genecraft's grants concentrate

GeneCraft, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2023. By volume, Genecraft sits between Gelmart Industries, Inc. and General Energy Recovery Inc..

Genecraft's three-year grant acceleration

GeneCraft, Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gelmart Industries

5
Gemex Systems

5
Genfleet Therapeu…

5
Gene Therapy Syst…

5
Genedesign

5
Genedia Biotech

5
General Dynamics…

5
General Energy Re…

5
Genecraft ◀

5

What this shows GeneCraft holds 5 patents at rank #47,150, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GeneCraft

By rank, the assignees closest to #47,150 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in GeneCraft's primary technology class.

Genecraft's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

GeneCraft, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	20.0%
2024	3	60.0%
2025partial year	1	20.0%

Which technologies does GeneCraft, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GeneCraft, Inc.'s patent record in context - here's where to go next.

GeneCraft, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #46,995 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GeneCraft, Inc. against Gelmart Industries, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.